Australia's Archer Materials gains on partnership for kidney testing device

Archer Materials

31/03/2025 02:08

** Shares of Archer Materials AXE.AX rise as much as 13.3% to A$0.34, highest level since February 26

** Semiconductor technology company enters partnership with Hylid Diagnostics to develop an at-home testing device for chronic kidney disease as part of its Biochip project

** About 279,150 shares change hands by 0057 GMT, 1.3 times the 30-day average volume of shares

** Stock down 48.3% this year, as of last close

 (Reporting by Sherin Sunny in Bengaluru)

 ((Sherin.Sunny@thomsonreuters.com;))